Mayinglong Pharmaceutical Group Co Ltd (600993) — Capital Reinvestment Ratio
Mayinglong Pharmaceutical Group Co Ltd (600993) has a Capital Reinvestment Ratio of 0.10x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥139.20 Million) in capital expenditures (CN¥13.73 Million). Check 600993 goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Mayinglong Pharmaceutical Group Co Ltd Capital Reinvestment Ratio (2003–2025)
This chart tracks Mayinglong Pharmaceutical Group Co Ltd's Capital Reinvestment Ratio across 22 annual periods. For the full cash flow conversion analysis, see Mayinglong Pharmaceutical Group Co Ltd operating cash flow efficiency.
Annual Capital Reinvestment Ratio for Mayinglong Pharmaceutical Group Co Ltd (2003–2025)
Year-by-year Capital Reinvestment Ratio for Mayinglong Pharmaceutical Group Co Ltd from 2003 to 2025. See Mayinglong Pharmaceutical Group Co Ltd free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.20x | CN¥600.44 Million | CN¥119.37 Million | ▼ -51.5% |
| 2024 | 0.41x | CN¥497.61 Million | CN¥203.85 Million | ▼ -0.4% |
| 2023 | 0.41x | CN¥604.07 Million | CN¥248.36 Million | ▲ +87.4% |
| 2022 | 0.22x | CN¥341.85 Million | CN¥75.01 Million | ▲ +101.3% |
| 2021 | 0.11x | CN¥597.17 Million | CN¥65.10 Million | ▼ -32.1% |
| 2020 | 0.16x | CN¥282.99 Million | CN¥45.41 Million | ▲ +70.2% |
| 2019 | 0.09x | CN¥491.58 Million | CN¥46.36 Million | ▲ +16.4% |
| 2018 | 0.08x | CN¥308.24 Million | CN¥24.96 Million | ▼ -31.2% |
| 2017 | 0.12x | CN¥356.17 Million | CN¥41.91 Million | ▼ -56.8% |
| 2016 | 0.27x | CN¥239.60 Million | CN¥65.24 Million | ▼ -59.8% |
| 2015 | 0.68x | CN¥182.85 Million | CN¥123.93 Million | ▼ -29.2% |
| 2014 | 0.96x | CN¥111.67 Million | CN¥106.87 Million | ▲ +48.6% |
| 2013 | 0.64x | CN¥129.94 Million | CN¥83.68 Million | ▲ +232.8% |
| 2012 | 0.19x | CN¥169.25 Million | CN¥32.75 Million | ▼ -67.4% |
| 2011 | 0.59x | CN¥75.37 Million | CN¥44.69 Million | ▲ +266.9% |
| 2009 | 0.16x | CN¥216.11 Million | CN¥34.93 Million | ▼ -49.5% |
| 2008 | 0.32x | CN¥102.59 Million | CN¥32.84 Million | ▼ -91.6% |
| 2007 | 3.80x | CN¥6.49 Million | CN¥24.65 Million | ▲ +1242.0% |
| 2006 | 0.28x | CN¥75.27 Million | CN¥21.32 Million | ▼ -54.0% |
| 2005 | 0.62x | CN¥58.43 Million | CN¥35.95 Million | ▲ +15.2% |
| 2004 | 0.53x | CN¥54.19 Million | CN¥28.94 Million | ▲ +148.1% |
| 2003 | 0.22x | CN¥67.52 Million | CN¥14.54 Million | — |